Staff Profile

Introduction

Biographical Sketch

Elaine Perry is a neuroscientist who has pursued a range of research activities focused on disorders of the human brain, pathological mechanisms and potential therapies.
Areas of research include dementia (Alzheimer’s, Lewy body and Vascular types), Parkinson’s disease, ageing , schizophrenia, depression and autism.ton Physic

Much of this research has focused on the role of the cholinergic system in pathogenesis and symptomatology, employing invaluable and ethically controlled human brain bank tissue. Pre and post synaptic cholinergic markers (including nicotinic and muscarinic receptors) assessed in autopsy material have been identified as being involved in symptoms such as cognitive dysfunction, hallucinations.

She is currently Curator of Dilston Physic Garden.  a Charity in Northumberland for Education and Research which links to school and student groups including the University Medical School. Research into  effects of medicinal plants on brain/ mind functions such as memory continues projects initiated at Newcastle University in conjunction with Durham University, King's College London and the Royal Botanic Gardens,Kew.

• Howes M-JR, Perry NSL, Vasquez-Londono C, Perry EK. Role of phytochemicals as nutraceuticals for cognitive functions affected in ageing. British Journal of Pharmacology 2020, 177(6), 1294-1315.
• Taylor J-P, Collerton D, LeBeau F, Perry E. Cholinergic pathology in dementia with Lewy bodies. In: Kosaka K, ed. Dementia with Lewy Bodies: Clinical and Biological Aspects. Tokyo: Springer Japan, 2016, pp.23-39.
• Mukaetova-Ladinska EB, Perry EK. Cholinergic changes in autistic spectrum disorders. 2015. In Press.
• Collerton D, Mosimann UP, Perry E. Future directions for research. In: The Neuroscience of Visual Hallucinations. Wiley Blackwell, 2015, pp.307-319.
• Mukaetova-Ladinska EB, Perry EK. Molecular basis of cholinergic changes in autism spectrum disorders and relevance for treatment interventions. In: The Molecular Basis of Autism. Springer New York, 2015, pp.307-335.
• Ekonomou A, Savva GM, Brayne C, Forster G, Francis PT, Johnson M, Perry EK, Attems J, Somani A, Minger SL, Ballard CG, on behalf of The Medical Research Council Cognitive Function and Ageing Neuropathology Study. Stage-Specific Changes in Neurogenic and Glial Markers in Alzheimer's Disease. Biological Psychiatry 2015, 77(8), 711-719.
• Collerton D, Mosimann UP, Perry E. The Neuroscience of Visual Hallucinations. Chichester: Wiley Blackwell, 2015.
• Collerton D, Mosimann UP, Perry E. The treatment of visual hallucinations at present and in the future. In: Collerton D; Mosimann UP; Perry E, ed. The Neuroscience of Visual Hallucinations. Chichester: Wiley Blackwell, 2015, pp.321-341.
• Mulugeta E, Vallortigara J, Francis PT, Hye A, Kalaria RN, Perry EK, Lovestone S, Ballard CG. Dynamin protein in stroke and vascular dementia. Neuroscience Letters 2014, 563, 118-122.
• Johnson M, Perry EK, Baker C, Attems J. Neurogenic marker alterations in the hippocampus in relation to cholinergic therapy in Lewy Body dementia. In: Proceedings of the 115th Meeting of the British Neuropathological Society. 2014, London: Wiley-Blackwell.
• Mukaetova-Ladinska EB, Andras A, Milne J, Abdel-All Z, Bohr I, Jaros E, Perry RH, Honer WG, Cleghorn A, Doherty J, McIntosh G, Perry EK, Kalaria RN, McKeith IG. Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies. Journal of Neuropathology and Experimental Neurology 2013, 72(1), 53-60.
• Mukaetova-Ladinska EB, Schaffer W, Bronnikova TV, Westwood J, Perry EK. Cholinergic therapy for autistic spectrum disorder. In: White, C.J., Tait, J.E, ed. Cholinesterase: Production, Uses and Health Effects. New York: Nova Science Publishers Inc, 2012, pp.33-66.
• Ekonomou A, Johnson M, Perry RH, Perry EK, Kalaria RN, Minger SL, Ballard CG. Increased neural progenitors in individuals with cerebral small vessel disease. Neuropathology and Applied Neurobiology 2012, 38(4), 344-353.
• Perry EK, Johnson M, Ekonomou A, Perry RH, Ballard C, Attems J. Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology. Neurobiology of Disease 2012, 47(2), 155-162.
• Mukaetova-Ladinska EB, Perry E, Baron M, Povey C. Ageing in people with autistic spectrum disorder. International Journal of Geriatric Psychiatry 2011, (online before print).
• Mukaetova-Ladinska EB, Westwood J, Perry EK. Biochemistry of autism: changes in serotonin, reelin and oxytocin. In: Roth, I., Rezaie, P, ed. Researching the Autism Spectrum: Contemporary Perspectives. Cambridge, UK: Cambridge University Press, 2011, pp.190-215.
• Collerton D, Perry E. Dreaming and hallucinations - Continuity or discontinuity? Perspectives from dementia with Lewy bodies. Consciousness and Cognition 2011, 20(4), 1016-1020.
• Ekonomou A, Ballard CG, Pathmanaban ON, Perry RH, Perry EK, Kalaria RN, Minger SL. Increased neural progenitors in vascular dementia. Neurobiology of Aging 2011, 32(12), 2152-2161.
• Johnson M, Ekonomou A, Hobbs C, Ballard CG, Perry RH, Perry EK. Neurogenic Marker Abnormalities in the Hippocampus in Dementia with Lewy Bodies. Hippocampus 2011, 21(10), 1126-1136.
• Bernstein HG, Johnson M, Perry RH, LeBeau FEN, Dobrowolny H, Bogerts B, Perry EK. Partial loss of parvalbumin-containing hippocampal interneurons in dementia with Lewy bodies. Neuropathology 2011, 31(1), 1-10.
• O'Sullivan SS, Johnson M, Williams DR, Revesz T, Holton JL, Lees AJ, Perry EK. The Effect of Drug Treatment on Neurogenesis in Parkinson's Disease. Movement Disorders 2011, 26(1), 45-50.
• Mukaetova-Ladinska E, Monteith R, Perry E. Cerebrospinal fluid biomarkers for Dementia with Lewy Bodies. International Journal of Alzheimer's Disease 2010, 536538.
• Mukaetova-Ladinska EB, Westwood J, Perry EK. Cholinergic component of autism spectrum disorder. In: Blatt, G.J, ed. The Neurochemical Basis of Autism: From Molecules to Minicolumns. Boston, Massachusetts, USA: Springer, 2010, pp.129-160.
• Laws V, Perry E. Near death experiences: A new algorithmic approach to verifying consciousness outside the brain. NeuroQuantology 2010, 8(2), 142-154.
• Perry EK, Mukaetova-Ladinska EB, Baron M. Autism: What about old age?. Bruxelles: Autism Europe, 2009. Available at: http://www.autismeurope.org/campaigns/right-to-adapted-care/autism-and-ageing/autism-what-about-old-age.html.
• Perry EK, Piggott MA, Court JA, Johnson M, Perry RH. Transmitters in the Developing and Senescent Human Brain. Annals of the New York Academy of Sciences 2006, 695(1), 69-72.
• Religa D, Johnson M, Kalaria R, Jaros E, McKeith IG, Perry R, Court JA, Naslund J, Perry EK. Decreased levels of amyloid beta peptide in the brains of smokers. In: European Journal of Neurology: 9th Congress of the EFNS. 2005, Athens, Greece: Wiley-Blackwell Publishing Ltd.
• Ballard C, Perry E, Lehmann D, Wesnes K, Holmes C. Butyrylcholinesterase: Impact on symptoms and progression of cognitive impairment in dementia. In: Neurobiology of Aging. 2004, Montreal, Quebec, Canada: Elsevier.
• Burn DJ, Perry EK, O'Brien JT, et al. Dementia with Lewy Bodies. In: Charney, D.S., Nestler, E.J, ed. Neurobiology of Mental Illness. Oxford, UK: Oxford University Press, 2004, pp.881-895.
• Norton SA, Perry ER, Haines TA, Dieffenbacher-Krall AC. Paleolimnological assessment of Grove and Plow Shop Ponds, Ayer, Massachusetts, USA--a superfund site. Journal of Environmental Monitoring 2004, 6(5), 457-465.
• Swartz R, Perry E, Daley J. The frequency of withdrawal from acute care is impacted by severe acute renal failure. Journal of Palliative Medicine 2004, 7(5), 676-682.
• Ballard C, O'Brien J, Reichelt K, Perry E. [abstract] A Randomized controlled trial of aromatherapy for dementia. International Psychogeriatrics 2003, 15(s2), 96-97.
• Meltzer HY, Perry E, Jayathilake K. Clozapine-induced weight gain predicts improvement in psychopathology. Schizophrenia Research 2003, 59(1), 19-27.
• Kulik CT, Perry EL, Pepper MB. Here comes the judge: the influence of judge personal characteristics on federal sexual harassment case outcomes. Law and Human Behavior 2003, 27(1), 69-86.
• Perry E. Nicotinic receptor pathologies in human brain. In: European Neuropsychopharmacology: 16th Congress of the European College of Neuropsychopharmacology. 2003, Prague, Czech Republic: Elsevier BV.
• Tildesley NTJ, Scholey AB, Kennedy DO, Wesnes KA, Hylands P, Perry EK, Ballard C. Acute mood and cognitive effects of a novel herbal extract (ONP-22) in healthy elderly volunteers. In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2002, Harrogate: Sage Publications Ltd.
• Perfect TJ, Moulin CJ, Conway MA, Perry E. Assessing the inhibitory account of retrieval-induced forgetting with implicit-memory tests. Journal of Experimental Psychology: Learning, Memory, and Cognition 2002, 28(6), 1111-1119.
• Perry EK, Piggott MA, Johnson M, Ballard CG, McKeith IG, Jaros E, Perry RH. Cholinergic and monoaminergic correlates of clinical symptoms in dementia with Lewy bodies. In: Mapping the Progress of Alzheimer's and Parkinson's Disease. 2002, Kyoto, Japan: Springer.
• Perry E. Cholinergic therapy for symptomatic treatment and disease modification. In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2002, Harrogate: Sage Publications Ltd.
• Kennedy DO, Scholey AB, Tildesley N, Perry EK, Wake G, Wesnes K. Cognitive and mood effects of acute administration of a Melissa officinalis with human CNS cholinergic receptor binding properties. In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2002, Harrogate: Sage Publications Ltd.
• Vulava VM, Perry E, Romanek CS, Seaman JC. Dissolved gases as partitioning tracers for determination of hydrogeological parameters. Environmental Science & Technology 2002, 36(2), 254-262.
• Perry EK, Burn DJ, McKeith IG, O'Brien J, Perry R. Lewy body diseases. In: Davis, K.L., Charney, D., Coyle, J.T., Nemeroff, C, ed. Neuropsychopharmacology: The Fifth Generation of Progress. Philadelphia: Lippincott Williams & Wilkins, 2002, pp.1301-1316.
• Perry E, Seegert G, Vondruska J, Lohner T, Lewis R. Modeling possible cooling-water intake system impacts on Ohio River fish populations. Scientific World Journal 2002, 2(s1), 58-80.
• Perry EK, Piggott MA, Johnson M, Ballard CG, McKeith IG, Burn DJ. Neurotransmitter correlates of neuropsychiatric symptoms in dementia with Lewy bodies. In: Bédard, M.-A, ed. Mental & Behavioural Dysfunction in Movement Disorders. Totowa, New Jersey, USA: Humana Press Inc, 2002, pp.285-294.
• Bednar I, Hellstrom-Lindahl E, Mousavi M, Nordberg A, Lee M, Johnson M, Hal R, Perry E, Court J. Nicotine treatment attenuates beta-amyloidosis in brain of transgenic APPsw mice. In: Neurobiology of Aging. 2002, Elsevier Inc.
• Teaktong T, Graham A, Court J, Johnson M, Hall R, Perry E, Perry R, Jaros E. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: Increased alpha 7 immunoreactivity of astrocytes in Alzheimer's disease. In: Neurobiology of Aging. 2002, Elsevier Inc.
• Johnson M, Court J, Perry E, Kalaria R, McKeith I, Jaros E, Perry R, Naslund J, Religa D. Tobacco use is associated with attenuation of beta-amyloidosis in hippocampus and entorhinal cortex of normal elderly individuals. In: Neurobiology of Aging. 2002, Elsevier Inc.
• Perry EL, McHugh MC. Trademarks: the "misunderstood" intellectual property. Nature Biotechnology 2002, 20(6), 627-628.
• Herwaldt BL, Neitzel DF, Gorlin JB, Jensen KA, Perry EH, Peglow WR, Slemenda SB, Won KY, Nace EK, Pieniazek NJ, Wilson M. Transmission of Babesia microti in Minnesota through four blood donations from the same donor over a 6-month period. Transfusion 2002, 42(9), 1154-1158.
• Kalaria RN, Ince PG, Kenny RA, McKeith IG, Morris CM, O'Brien JT, Perry EK, Perry RH, Edwardson JA. Multiple substrates of late-onset dementia: implications for brain protection. Ageing Vulnerability: Causes and Interventions: Novartis Foundation Symposium 235 2001, 235, 49-65.
• Perry E, Goodchild R, Piggott M. Neurochemical pathology in degenerative dementias. In: Hodges, J.R, ed. Early-Onset Dementia: A Multidisciplinary Approach. Oxford: Oxford University Press, 2001, pp.190-226.
• Fleischer RC, Perry EA, Muralidharan K, Stevens EE, Wemmer CM. Phylogeography of the asian elephant (Elephas maximus) based on mitochondrial DNA. Evolution 2001, 55(9), 1882-1892.
• Perry E. Cholinergic components of cognitive and neuropsychiatric features of human brain aging. In: Proceedings of the British Pharmacological Society Meeting. 2000, University of Bradford, UK: British Journal of Pharmacology.
• Perry NSL, Houghton PJ, Theobald A, Jenner P, Perry EK. In-vitro inhibition of human erythrocyte acetylcholinesterase by Salvia lavandulaefolia essential oil and constituent terpenes. Journal of Pharmacy and Pharmacology 2000, 52(7), 895-902.
• Mantle D, Pickering AT, Perry EK. Medicinal plant extracts for the treatment of dementia: A review of their pharmacology, efficacy and tolerability. CNS Drugs 2000, 13(3), 201-213.
• Perry E, Walker M, Grace J, Perry R. Acetylcholine in mind: a neurotransmitter correlate of consciousness?. Trends in Neurosciences 1999, 22(6), 273-280.
• Perry EK, Lee M, Martin-Ruiz CM, et al. Cholinergic component of vascular dementia. Alzheimer's Reports 1999, 2(Suppl), 576.
• Perry E, Grace J, Perry R, McKeith I. Cholinergic mechanisms of psychosis and clinical efficacy of cholinergic drugs. In: 40th Annual Meeting of the Scandinavian Society for Psychopharmacology. 1999, Copenhagen, Denmark: Informa Healthcare.
• Perry E, Walker M, Perry R. Consciousness in mind: a correlate for ACh? Reply to Hölscher. Trends in Neurosciences 1999, 22(12), 542-543.
• Mantle D, Falkous G, Perry EK. Effect of flavonoids on protease activities in human skeletal muscle tissue in vitro. Clinica Chimica Acta 1999, 285(1-2), 13-20.
• Court J, Spurden D, Lloyd S, McKeith I, Ballard C, Cairns N, Kerwin R, Perry R, Perry E. Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus. Journal of Neurochemistry 1999, 73(4), 1590-1597.
• Ballard C, Holmes C, McKeith I, Neill D, O'Brien J, Cairns N, Lantos P, Perry E, Ince P, Perry R. Psychiatric morbidity in dementia with Lewy bodies: A prospective clinical and neuropathological comparative study with Alzheimer's disease. American Journal of Psychiatry 1999, 156(7), 1039-1045.
• McKeith IG, Perry EK, Perry RH, and for the Consortium on Dementia with Lewy Bodies. Report of the second dementia with Lewy body international workshop - Diagnosis and treatment. In: Second International Workshop of the Consortium on Dementia with Lewy Bodies. 1999, Newcastle upon Tyne.
• P. G. Ince, E. K. Perry and C. M. Morris. Dementia with Lewy bodies. A distinct non-Alzheimer dementia syndrome?. Brain Pathology 1998, 8, 299-324.
• Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK, Morris CM, Perry RH, Ferrier IN, Court JA. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 1997, 7(6), 479-484.
• Perry RH, McKeith IG, Perry EK. Dementia with Lewy Bodies : Clinical, Pathological and Treatment Issues. Cambridge: Cambridge University Press, 1996.
• Perry EK, Perry RH. Acetylcholine and Hallucinations - Disease-Related Compared to Drug-Induced Alterations in Human Consciousness. Brain and Cognition 1995, 28(3), 240-258.
• Perry EK, Morris CM, Court JA, Cheng A, Fairbairn AF, McKeith IG, Irving D, Brown A, Perry RH. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology. Neuroscience 1995, 64(2), 385-395.
• Perry EK, Perry RH, McKeith IG, Piggott MA, Smith P, Marshall E. Clinical, pathological and neurochemical characteristics of Lewy body dementia. In: Alzheimer's and Parkinson's Diseases: Recent Developments. Springer US, 1995, pp.77-86.
• Ince PG, Harrington CR, Wischik CM, Raghavan R, Perry EK, Perry RH. Cortical tau-protein and neurofibrillary tangles in lewy body dementia, alzheimers-disease, parkinsons-disease and controls. In: Fourth International Conference on Alzheimer's Disease and Related Disorders. 1994, Minneapolis, MN: Elsevier Inc.
• Marshall EF, Perry EK, Perry RH, McKeith IG, Fairbairn AF, Thompson P. Dopamine metabolism in postmortem caudate-nucleus in neurodegenerative disorders. Neuroscience Research Communications 1994, 14(1), 17-25.
• Piggott MA, Perry EK, McKeith IG, Marshall E, Perry RH. DRD2 Ser311/Cys311 polymorphism in schizophrenia. Lancet 1994, 343(8904), 1045-1045.
• Raghavan R, Khinnu C, Brown AG, Day KA, Tyrer SP, Ince PG, Perry EK, Perry RH. Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (Trisomy 21). NeuroReport 1994, 5(11), 1393-1396.
• Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik CM. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. American Journal of Pathology 1994, 145(6), 1472-1484.
• Perry EK, Haroutunian V, Davis KL, Levy R, Lantos P, Eagger S, Honavar M, Dean A, Griffiths M, McKeith IG, Perry RH. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. NeuroReport 1994, 5(7), 747-749.
• Perry EK, Kerwin JM, Perry RH. On neuronal ill health. Trends in Neurosciences 1994, 17(2), 51-51.
• Harrington CR, Perry RH, Perry EK, Hurt J, McKeith JG, Roth M, Wischik CM. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tan protein. Dementia 1994, 5(5), 215-228.
• Perry EK, Court JA, Johnson M, Smith CJ, James V, Cheng AV, Kerwin JM, Morris CM, Piggott MA, Edwardson JA, Birdsall NJM, Turner JT, Perry RH. Autoradiographic comparison of cholinergic and other transmitter receptors in the normal human hippocampus. Hippocampus 1993, 3(3), 307-315.
• Johnson M, Perry EK, Ince PG, Shaw PJ, Perry RH. Autoradiographic comparison of the distribution of [³H]MK801 and [³H]CNQX in the human cerebellum during development and aging. Brain Research 1993, 615(2), 259-266.
• Perry EK, Irving D, Kerwin JM, McKeith IG, Thompson P, Collerton D, Fairbairn AF, Ince PG, Morris CM, Cheng AV, Perry RH. Cholinergic Transmitter and Neurotrophic Activities in Lewy Body Dementia: Similarity to Parkinson's and Distinction from Alzheimer Disease. Alzheimer Disease & Associated Disorders 1993, 7(2), 69-79.
• Kerwin JM, Morris CM, Johnson M, Perry RH, Perry EK. Hippocampal p75 Nerve Growth Factor Receptor Immunoreactivity in Development, Normal Aging and Senescence. Acta Anatomica 1993, 147(4), 216-222.
• Perry EK, Marshall E, Thompson P, McKeith IG, Collerton D, Fairbairn AF, Ferrier IN, Irving D, Perry RH. Monoaminergic activities in Lewy body dementia: relation to hallucinosis and extrapyramidal features. Journal of Neural Transmission. Parkinson's Disease and Dementia Section 1993, 6(3), 167-177.
• Piggott MA, Perry EK, Perry RH, Scott D. N-methyl-D-aspartate (NMDA) and non-NMDA binding sites in developing human frontal cortex. Neuroscience Research Communications 1993, 12(1), 9-16.
• Court JA, Perry EK, Johnson M, Piggott MA, Kerwin JA, Perry RH, Ince PG. Regional patterns of cholinergic and glutamate activity in the developing and aging human brain. Developmental Brain Research 1993, 74(1), 73-82.
• Perry EK, Piggott MA, Court JA, Johnson M, Perry RH. Transmitters in the Developing and Senescent Human Brain. In: Alzheimer's Disease: Amyloid Precursor Proteins, Signal Transduction, and Neuronal Transplantation. 1993.
• Piggott MA, Perry EK, Perry RH, Court JA. [³H]MK-801 binding to the NMDA receptor complex, and its modulation in human frontal cortex during development and aging. Brain Research 1992, 588(2), 277-286.
• Court JA, Piggott MA, Perry EK, Barlow RB, Perry RH. Age-associated decline in high-affinity nicotine binding in human brain frontal-cortex does not correlate with the changes in choline-acetyltransferase activity. Neuroscience Research Communications 1992, 10(3), 125-133.
• Perry EK, Court JA, Johnson M, Piggott MA, Perry RH. Autoradiographic distribution of [³H]nicotine binding in human cortex: Relative abundance in subicular complex. Journal of Chemical Neuroanatomy 1992, 5(5), 399-405.
• Perry EK, Johnson M, Kerwin JM, Piggott MA, Court JA, Shaw PJ, Ince PG, Brown A, Perry RH. Convergent cholinergic activities in aging and Alzheimer's disease. Neurobiology of Aging 1992, 13(3), 393-400.
• Piggott MA, Perry EK, Sahgal A, Perry RH. Examination of Parameters Influencing [³H]MK-801 Binding in Postmortem Human Cortex. Journal of Neurochemistry 1992, 58(3), 1001-1008.
• Kerwin JM, Morris CM, Perry RH, Perry EK. Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's disease. Neuroscience Letters 1992, 143(1-2), 101-104.
• Kerwin JM, Morris CM, Perry RH, Perry EK. Nerve Growth Factor Receptor-Like Immunoreactivity in the Human Spinal Cord. Acta Anatomica 1992, 144(4), 348-353.
• McKeith I, Fairbairn A, Perry RH, Thompson P, Perry EK. Neuroleptic Sensitivity in Patients with Senile Dementia of Lewy Body Type. BMJ 1992, 305(6855), 673-678.
• McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK. Operational criteria for senile dementia of Lewy body type (SDLT). Psychological Medicine 1992, 22(4), 911-922.
• Perry EK, Irving D, Perry RH. Cholinergic Controversies. Trends in Neurosciences 1991, 14(11), 483-484.
• Cheng AVT, Ferrier IN, Morris CM, Jabeen S, Sahgal A, McKeith IG, Edwardson JA, Perry RH, Perry EK. Cortical serotonin-S₂ receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases. Journal of the Neurological Sciences 1991, 106(1), 50-55.
• Leake A, Perry EK, Perry RH, Jabeen S, Fairbairn AF, McKeith IG, Ferrier IN. Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: comparison with Parkinson's disease and severity correlations. Biological Psychiatry 1991, 29(4), 357-364.
• Xuereb JH, Perry RH, Candy JM, Perry EK, Marshall E, Bonham JR. Nerve cell loss in the thalamus in Alzheimer's disease and Parkinson's disease. Brain 1991, 114(3), 1363-1379.
• Perry EK, McKeith I, Thompson P, Marshall E, Kerwin J, Jabeen S, Edwardson JA, Ince P, Blessed G, Irving D, Perry RH. Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease. Annals of the New York Academy of Sciences 1991, 640, 197-202.
• Ghanbari HA, Miller BE, Haigler HJ, Arato M, Bissette G, Davies P, Nemeroff CB, Perry EK, Perry R, Ravid R, Swaab DF, Whetsell WO, Zemlan FP. Biochemical Assay of Alzheimer's Disease - Associated Protein(s) in Human Brain Tissue: A Clinical Study. JAMA - Journal of the American Medical Association 1990, 263(21), 2907-2910.
• Perry EK, Smith CJ, Court JA, Perry RH. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types. Journal of Neural Transmission – Parkinson’s Disease and Dementia Section 1990, 2(3), 149-158.
• Leake A, Perry EK, Perry RH, Fairbairn AF, Ferrier IN. Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression. Biological Psychiatry 1990, 28(7), 603-608.
• Xuereb JH, Candy JM, Perry EK, Perry RH, Marshall E, Bonham JR. Distribution of neurofibrillary tangle formation and [³H]-D-aspartate receptor binding in the thalamus in the normal elderly brain, in Alzheimer's disease and in Parkinson's disease. Neuropathology and Applied Neurobiology 1990, 16(6), 477-488.
• Perry EK, Marshall E, Kerwin J, Smith CJ, Jabeen S, Cheng AV, Perry RH. Evidence of a Monoaminergic-Cholinergic Imbalance Related to Visual Hallucinations in Lewy Body Dementia. Journal of Neurochemistry 1990, 55(4), 1454-1456.
• Court JA, Perry EK, Perry RH. Nicotine inhibits the release of H3 GABA from rat and human cerebral cortex, in vitro. Neuroscience Research Communications 1990, 7(1), 9-15.
• Xuereb JH, Perry EK, Candy JM, Bonham JR, Perry RH, Marshall E. Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease. Journal of the Neurological Sciences 1990, 99(2-3), 185-197.
• Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type: A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. Journal of the Neurological Sciences 1990, 95(2), 119-139.
• Perry EK, Kerwin J, Perry RH, Blessed G, Fairbairn AF. Visual hallucinations and the cholinergic system in dementia. Journal of Neurology, Neurosurgery and Psychiatry 1990, 53(1), 88-88.
• Perry RH, Irving D, Blessed G, Perry EK, Fairbairn AF. Clinically and neuropathologically distinct form of dementia in the elderly. Lancet 1989, 1(8630), 165-166.
• Mantle D, Lauffart B, Perry EK, Perry RH. Comparison of major cortical aminopeptidase activity in normal brain and brain from patients with Alzheimer's disease. Journal of the Neurological Sciences 1989, 89(2-3), 227-234.
• Johnson M, Perry RH, Charlton FG, Moses MA, Court JA, Perry EK. Distribution of [³H]MK801 binding in the normal aged human hippocampus. Brain Research 1989, 499(1), 184-187.
• Perry EK, Smith CJ, Perry RH, Johnson M, Fairbairn AF. Nicotinic (³H nicotine) receptor binding in human brain: characterization and involvement in cholinergic neuropathology. Neuroscience Research Communications 1989, 5(2), 117-124.
• Perry EK, Smith CJ, Perry RH, Whitford C, Johnson M, Birdsall NJ. Regional distribution of muscarinic and nicotinic cholinergic receptor binding activities in the human brain. Journal of Chemical Neuroanatomy 1989, 2(4), 189-199.
• Perry RH, Irving D, Blessed G, Perry EK, Fairbairn AF. Senile dementia of Lewy body type and spectrum of Lewy body disease. Lancet 1989, 1(8646), 1088-1088.
• Cross AJ, Slater P, Perry EK, Perry RH. An autoradiographic analysis of serotonin receptors in human temporal cortex: Changes in Alzheimer-type dementia. Neurochemistry International 1988, 13(1), 89-96.
• Smith CJ, Perry EK, Perry RH, Candy JM, Johnson M, Bonham JR, Dick DJ, Fairbairn A, Blessed G, Birdsall NJM. Muscarinic Cholinergic Receptor Subtypes in Hippocampus in Human Cognitive Disorders. Journal of Neurochemistry 1988, 50(3), 847-856.
• McKeith IG, Marshall EF, Ferrier IN, Armstrong MM, Kennedy WN, Perry RH, Perry EK, Eccleston D. 5-HT receptor binding in post-mortem brain from patients with affective disorder. Journal of Affective Disorders 1987, 13(1), 67-74.
• Cross AJ, Slater P, Candy JM, Perry EK, Perry RH. Glutamate deficits in Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry 1987, 50(3), 357-358.
• Smith CJ, Perry EK, Perry RH, Fairbairn AF, Birdsall NJM. Guanine nucleotide modulation of muscarinic cholinergic receptor binding in postmortem human brain - A preliminary study in Alzheimer's disease. Neuroscience Letters 1987, 82(2), 227-232.
• Atack JR, Perry EK, Bonham JR, Boakes R, Candy JM. Loss and recovery of acetylcholinesterase molecular forms in the fornix-lesioned rat hippocampus. Neuroscience Letters 1987, 79(1-2), 179-184.
• Atack JR, Perry EK, Bonham JR, Perry RH. Molecular forms of acetylcholinesterase and butyrylcholinesterase in human plasma and cerebrospinal fluid. Journal of Neurochemistry 1987, 48(6), 1845-1850.
• Atack JR, Perry EK, Bonham JR, Candy JM, Perry RH. Molecular Forms of Butyrylcholinesterase in the Human Neocortex During Development and Degeneration of the Cortical Cholinergic System. Journal of Neurochemistry 1987, 48(6), 1687-1692.
• Perry EK, Perry RH, Smith CJ, Dick DJ, Candy JM, Edwardson JA, Fairbairn A, Blessed G. Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases. Journal of Neurology, Neurosurgery and Psychiatry 1987, 50(6), 806-809.
• Taylor GR, Carter GI, Crow TJ, Johnson JA, Fairbairn AF, Perry EK, Perry RH. Recovery and measurement of RNA in Alzheimer's disease by molecular hybridisation. Journal of Neurology, Neurosurgery and Psychiatry 1987, 50(3), 356-356.
• Cross AJ, Slater P, Simpson M, Royston C, Deakin JFW, Perry RH, Perry EK. Sodium dependent D-[³H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases. Neuroscience Letters 1987, 79(1-2), 213-217.
• Candy JM, Oakley AE, Klinowski J, Carpenter TA, Perry RH, Atack JR, Perry EK, Blessed G, Fairbairn A, Edwardson JA. Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet 1986, 1(8477), 354-357.
• Perry EK, Perry RH, Smith CJ, Purohit D, Bonham J, Dick DJ, Candy JM, Edwardson JA, Fairbairn A. Cholinergic receptors in cognitive disorders. Canadian Journal of Neurological Sciences 1986, 13(suppl. 4), 521-527.
• Perry EK, Perry RH. CNS cholinergic markers and Alzheimer's disease. Neurobiology of Aging 1986, 7(5), 390-391.
• Atack JR, Perry EK, Bonham JR, Candy JM, Perry RH. Molecular Forms of Acetylcholinesterase and Butyrylcholinesterase in the Aged Human Central Nervous System. Journal of Neurochemistry 1986, 47(1), 263-277.
• Perry EK, Smith CJ, Atack JR, Candy JM, Johnson M, Perry RH. Neocortical Cholinergic Enzyme and Receptor Activities in the Human Fetal Brain. Journal of Neurochemistry 1986, 47(4), 1262-1269.
• Taylor GR, Carter GI, Crow TJ, Johnson JA, Fairbairn AF, Perry EK, Perry RH. Recovery and measurement of specific RNA species from postmortem brain tissue: a general reduction in Alzheimer's disease detected by molecular hybridization. Experimental and Molecular Pathology 1986, 44(1), 111-116.
• Candy JM, Perry EK, Perry RH, Court JA, Oakley AE, Edwardson JA. The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease. In: D.F. Swaab, E. Fliers, M. Mirmiran, W.A. Van Gool and F. Van Haaren, ed. Aging of the Brain and Alzheimer's Disease. Amsterdam; Oxford: Elsevier, 1986, pp.105-132.
• Perry EK, Perry RH. Unfolding the nature of senile plaque amyloid. Neurobiology of Aging 1986, 7(6), 437-439.
• Perry EK, Perry RH. A review of neuropathological and neurochemical correlates of Alzheimer's disease. Danish Medical Bulletin 1985, 32, 27-34.
• Edwardson JA, Bloxham CA, Candy JM, Oakley AE, Perry RH, Perry EK. Alzheimer's Disease and Parkinson's Disease: Pathological and Biochemical Changes Associated with Dementia. In: Iversen, SD, ed. Psychopharmacology: Recent Advances and Future Prospects. Oxford: Oxford University Press, 1985, pp.131-145.
• Atack JR, Perry EK, Perry RH, Wilson ID, Bober MJ, Blessed G, Tomlinson BE. Blood acetyl- and butyrylcholinesterases in senile dementia of Alzheimer type. Journal of the Neurological Sciences 1985, 70(1), 1-12.
• Perry EK, Curtis M, Dick DJ, Candy JM, Atack JR, Bloxham CA, Blessed G, Fairbairn A, Tomlinson BE, Perry RH. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry 1985, 48(5), 413-421.
• Candy JM, Edwardson JA, Klinowski J, Oakley AE, Perry EK, Perry RH. Co‑localization of Aluminium and Silicon in Senile Plaques: Implications for the Neurochemical Pathology of Alzheimer's Disease. In: Traber, J; Gispen, WH, ed. Senile Dementia of the Alzheimer Type. Berlin: Springer Verlag, 1985, pp.183-197.
• Candy JM, Perry EK, Perry RH, Bloxham CA, Thompson J, Johnson M, Oakley AE, Edwardson JA. Evidence for the early prenatal development of cortical cholinergic afferents from the nucleus of Meynert in the human foetus. Neuroscience Letters 1985, 61(1-2), 91-95.
• Perry EK, Perry RH. New insights into the nature of senile (Alzheimer-type) plaques. Trends in Neurosciences 1985, 8(7), 301-303.
• Candy JM, Gascoigne AD, Biggins JA, Smith AI, Perry RH, Perry EK, McDermott JR, Edwardson JA. Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease. Journal of the Neurological Sciences 1985, 71(2-3), 315-323.
• Perry EK, Perry RH, Candy JM, Fairbairn AF, Blessed G, Dick DJ, Tomlinson BE. Cortical serotonin-S₂ receptor binding abnormalities in patients with Alzheimer's disease: Comparisons with Parkinson's disease. Neuroscience Letters 1984, 51(3), 353-357.
• Perry RH, Perry EK. Implications of Neuropathological and Neurochemical Abnormalities in Alzheimer's Disease. In: Knook, DL; Caderini, G; Amaducci, L, ed. Topics in Aging Research in Europe. Leiden: Eurage, 1984, pp.59-64.
• Perry EK, Atack JR, Perry RH, Hardy JA, Dodd PR, Edwardson JA, Blessed G, Tomlinson BE, Fairbairn AF. Intralaminar Neurochemical Distributions in Human Midtemporal Cortex: Comparison Between Alzheimer's Disease and the Normal. Journal of Neurochemistry 1984, 42(5), 1402-1410.
• Perry RH, Perry EK. Neurochemical Pathology of Alzheimer's Disease - The Cholinergic Concept. In: Kay, DW; Burrows, G, ed. Handbook of Studies on Psychiatry and Old Age. Amsterdam: Elsevier Science Publishers, 1984, pp.119-132.
• Bloxham CA, Perry EK, Perry RH, Oakley AE, Edwardson JA, Candy JM. Neuropathological and Neurochemical Correlates of Alzheimer‑type and Parkinsonian Dementia. In: Wurtman, R; Corkin, SH; Growdon, JH, ed. Alzheimer's Disease: Advances in Basic Research and Therapies. Center for Brain Sciences and Metabolism Charitable Trust, 1984, pp.39-52.
• Perry EK, Candy JM, Perry RH. Neuropathology of the cholinergic system in the human brain. Developments in Neuroscience 1984, 17, 279-282.
• Crow TJ, Cross AJ, Cooper SJ, Deakin JFW, Ferrier IN, Johnson JA, Joseph MH, Owen F, Poulter M, Lofthouse R, Corsellis JAN, Chambers DR, Blessed G, Perry EK, Perry RH, Tomlinson BE. Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology 1984, 23(12, part 2), 1561-1569.
• Candy JM, Oakley AE, Atack J, Perry RH, Perry EK, Edwardson JA. New observations on the nature of senile plaque cores. Developments in Neuroscience 1984, 17, 301-304.
• Cross AJ, Crow TJ, Johnson JA, Perry EK, Perry RH, Blessed G, Tomlinson BE. Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type. Journal of the Neurological Sciences 1984, 64(2), 109-117.
• Perry RH, Candy JM, Perry EK, Thompson J, Oakley AE. The substantia innominata and adjacent regions in the human brain: histochemical and biochemical observations. Journal of Anatomy 1984, 138, 713-732.
• Perry EK, Perry RH. Acetylcholinesterase in Alzheimer's Disease. In: Reisberg, B, ed. Alzheimer's Disease: the Standard Reference. New York: The Free Press, 1983, pp.93-99.
• Perry EK, Marshall EF, Blessed G, Tomlinson BE, Perry RH. Decreased imipramine binding in the brains of patients with depressive illness. British Journal of Psychiatry 1983, 142, 188-192.
• Perry EK, Perry RH. Human brain neurochemistry - Some postmortem problems. Life Sciences 1983, 33(18), 1733-1743.
• Atack JR, Perry EK, Bonham JR, Perry RH, Tomlinson BE, Blessed G, Fairbairn A. Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: Selective loss of the intermediate (10S) form. Neuroscience Letters 1983, 40(2), 199-204.
• Cross AJ, Crow TJ, Johnson JA, Joseph MH, Perry EK, Perry RH, Blessed G, Tomlinson BE. Monoamine metabolism in senile dementia of Alzheimer type. Journal of the Neurological Sciences 1983, 60(3), 383-392.
• Biggins JA, Perry RH, Candy JM, Perry EK, Bloxham CA, Johnson M, Edwardson JA. Neurotensin immunoreactivity and choline acetyltransferase activity in the cerebral cortex in Parkinson's disease. In: Bayliss & Starling Society National Scientific Meeting. 1983, Newcastle upon Tyne: Elsevier BV.
• Candy JM, Perry RH, Perry EK, Irving D, Blessed G, Fairbairn AF, Tomlinson BE. Pathological changes in the nucleus of meynert in Alzheimer's and Parkinson's diseases. Journal of the Neurological Sciences 1983, 59(2), 277-289.
• Biggins JA, Perry EK, McDermott JR, Smith AI, Perry RH, Edwardson JA. Post mortem levels of thyrotropin-releasing hormone and neurotensin in the amygdala in Alzheimer's disease, schizophrenia and depression. Journal of the Neurological Sciences 1983, 58(1), 117-122.
• Candy JM, Gascoigne AD, Biggins JA, Smith AI, Perry RH, Perry EK, McDermott JR, Edwardson JA. Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease. In: Bayliss & Starling Society National Scientific Meeting. 1983, Newcastle upon Tyne: Elsevier BV.
• Perry RH, Candy JM, Perry EK. Some Observations and Speculations Concerning the Cholinergic System and Neuropeptides in Alzheimer's Disease. In: Terry, RD; Katzman, R, ed. Biological Aspects of Alzheimer's Disease. New York: Cold Spring Harbor Laboratory, 1983, pp.351-361.
• Candy JM, Perry RH, Perry EK, Biggins JA, Thompson JE, Irving D. Transmitter Systems in Alzheimer's Disease. In: Gispen WH; Traber, J, ed. Aging of the Brain. Amsterdam: Elsevier Science Publishers, 1983, pp.29-48.
• Perry RH, Candy JM, Perry EK, Irving D, Blessed G, Fairbairn AF, Tomlinson BE. Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of meynert in Alzheimer's disease. Neuroscience Letters 1982, 33(3), 311-315.
• Candy JM, Perry RH, Perry EK, Oakley A, Smith I, Edwardson JA. Factors influencing the formation and stability of substance P fibrillary polymers. In: Bayliss and Starling Society National Scientific Meeting. 1982, London: Elsevier BV.
• Perry EK, Perry RH, Tomlinson BE. Influence of agonal status on some neurochemical activities of postmortem human brain tissue. Neuroscience Letters 1982, 29(3), 303-307.
• Blessed G, Crow TJ, Cross AJ, Perry EK, Perry RH, Tomlinson BE. Monoaminergic Function in Postmortem Brain in Depression. In: 13th CINP Congress. 1982, Jerusalem, Israel.
• Perry RH, Wilson ID, Bober MJ, Atack J, Blessed G, Tomlinson BE, Perry EK. Plasma and erythrocyte acetylcholinesterase in senile dementia of alzheimer type. Lancet 1982, 319(8264), 174-175.
• Perry RH, Perry EK. The Ageing Brain and its Pathology. In: Levy, R; Post, F, ed. The Psychiatry of Late Life. Oxford: Blackwell Scientific Publications, 1982, pp.9-67.
• Perry EK, Perry RH. The cholinergic system in Alzheimer's disease. Trends in Neurosciences 1982, 5(8), 261-262.
• Perry EK, Perry RH. Brain Biochemistry in Dementia of Alzheimer‑type. In: Clifford Rose, F, ed. Metabolic Disorders of the Nervous System. Bath: The Pitman Press, 1981, pp.382-417.
• Perry EK, Perry RH. Cortical Neurotransmitter and Neuropeptide Activities in Alzheimer's disease. In: Perris, C; Struwe, G; Jansson, B, ed. Biological Psychiatry. Amsterdam: Elsevier/North Holland Biomedical Press, 1981, pp.961-964.
• Oakley AE, Perry RH, Candy JM, Perry EK. Electron microscopic appearances and implications of neuropeptide fibrillary forms. Neuropeptides 1981, 2(1), 1-11.
• Candy JM, Oakley AE, Perry EK, Perry RH. Electron-microscopic demonstration of fibrillary forms of small peptides common to brain and gut. In: Proceedings of the Physiological Society. 1981, Wiley-Blackwell Publishing Ltd.
• Candy JM, Oakley AE, Perry EK, Perry RH. Existence in vitro of fibrillary aggregates of substance P, cholecystokinin octapeptide, somatostatin and related molecules. In: Proceedings of the Physiological Society. 1981, Wiley-Blackwell Publishing Ltd.
• Perry EK, Blessed G, Tomlinson BE, Perry RH, Crow TJ, Cross AJ, Dockray GJ, Dimaline R, Arregui A. NEUROCHEMICAL ACTIVITIES IN HUMAN TEMPORAL-LOBE RELATED TO AGING AND ALZHEIMER-TYPE CHANGES. Neurobiology of Aging 1981, 2(4), 251-256.
• Perry EK, Tomlinson BE, Blessed G, Perry RH, Cross AJ, Crow TJ. Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease. Journal of the Neurological Sciences 1981, 51(2), 279-287.
• Perry RH, Dockray GJ, Dimaline R, Perry EK, Blessed G, Tomlinson BE. Neuropeptides in Alzheimer's disease, depression and schizophrenia : A post mortem analysis of vasoactive intestinal peptide and cholecystokinin in cerebral cortex. Journal of the Neurological Sciences 1981, 51(3), 465-472.
• Perry EK, Tomlinson BE, Blessed G, Perry RH, Cross AJ, Crow TT. Noradrenergic and cholinergic systems in senile dementia of alzheimer type. Lancet 1981, 318(8238), 149-149.
• Perry EK, Oakley AE, Candy JM, Perry RH. Properties and possible significance of substance P and insulin fibrils. Neuroscience Letters 1981, 25(3), 321-325.
• Cross AJ, Crow TJ, Perry EK, Perry RH, Blessed G, Tomlinson BE. Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease. BMJ 1981, 282(6258), 93-94.
• Richter JA, Perry EK, Tomlinson BE. Acetylcholine and choline levels in post-mortem human brain tissue: Preliminary observations in Alzheimer's disease. Life Sciences 1980, 26(20), 1683-1689.
• Perry EK. Cholinergic system in old age and Alzheimer's disease. Age and Ageing 1980, 9(1), 1-8.
• Perry EK, Perry RH, Tomlinson BE, Blessed G, Gibson PH. Coenzyme a-acetylating enzymes in Alzheimer's disease: Possible cholinergic ‘compartment’ of pyruvate dehydrogenase. Neuroscience Letters 1980, 18(1), 105-110.
• Tarbit I, Perry EK, Perry RH, Blessed G, Tomlinson BE. Hippocampal Free Amino Acids in Alzheimer's Disease. Journal of Neurochemistry 1980, 35(5), 1246-1249.
• Perry RH, Blessed G, Perry EK, Tomlinson BE. Histochemical observations on cholinesterase activities in the brains of elderly normal and demented (Alzheimer-type) patients. Age and Ageing 1980, 9(1), 9-16.
• Perry RH, Perry EK. Histochemistry of Brain Cholinesterases in Normal Old Age and Alzheimer's disease. In: Amaducci, A; Davison, A; Antuono, P, ed. Aging of the Brain and Dementia. New York: Raven Press, 1980, pp.105-110.
• Perry EK, Perry RH. The cholinergic system in Alzheimer's disease. In: PJ Roberts, ed. Biochemistry of Dementia. Chichester: John Wiley & Sons Ltd, 1980, pp.135-183.
• Perry EK, Blessed G, Perry RH, Tomlinson BE. Brain Biochemistry in Schizophrenia. LANCET 1978, 1(8054), 35-36.
• Perry EK, Perry RH, Blessed G, Tomlinson BE. Changes in brain Cholinesterases in senile dementia of Alzheimer type. Neuropathology and Applied Neurobiology 1978, 4(4), 273-277.
• Perry EK, Perry RH, Gibson PH, Blessed G, Tomlinson BE. A cholinergic connection between normal aging and senile dementia in the human hippocampus. Neuroscience Letters 1977, 6(1), 85-89.
• Perry EK, Perry RH. Cholinergic and gaba systems in dementia and normal old-age. British Journal of Psychiatry 1977, 131(3), 319-319.
• Perry EK, Perry RH, Taylor MJ, Tomlinson BE. Circadian Variation in Human Brain Enzymes. Lancet 1977, 2(8014), 753-754.
• Perry EK, Perry RH, Tomlinson BE. Circadian variations in cholinergic enzymes and muscarinic receptor binding in human cerebral cortex. Neuroscience Letters 1977, 4(3-4), 185-189.
• Perry EK, Perry RH, Tomlinson BE. Dietary Lecithin supplements in Dementia of Alzheimer Type?. Lancet 1977, 2(8031), 242-243.
• Perry EK, Perry RH, Taylor MJ, Tomlinson BE. Evidence of a circadian fluctuation in neurotransmitter enzyme activities measured in autopsy human brain. Journal of Neurochemistry 1977, 29(3), 593-594.
• Perry RH, Tomlinson BE, Taylor MJ, Perry EK. Human Brain Temperature at Necropsy: a Guide in Postmortem Biochemistry. Lancet 1977, 1(8001), 38-38.
• Perry EK, Gibson PH, Blessed G, Perry RH, Tomlinson BE. Neurotransmitter enzyme abnormalities in senile dementia ☆: Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. Journal of the Neurological Sciences 1977, 34(2), 247-265.